Stifel Financial Corp Grifols Sa Transaction History

Stifel Financial Corp

$99.8 Billion
Q2 2025

A detailed history of Stifel Financial Corp transactions in Grifols Sa stock. As of the latest transaction made, Stifel Financial Corp holds 155,512 shares of GRFS stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,512

Previous 144,682 7.49%

Holding current value

$1.45 Million

Previous $1.03 Million 36.67%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.49 - $9.09 $70,286 - $98,444	10,830 Added 7.49%	155,512 $1.41 Million
Q1 2025 May 13, 2025	BUY	$6.62 - $8.71 $137,722 - $181,202	20,804 Added 16.79%	144,682 $1.03 Million
Q4 2024 Feb 13, 2025	BUY	$6.99 - $9.55 $44,854 - $61,282	6,417 Added 5.46%	123,878 $921,000
Q3 2024 Nov 14, 2024	BUY	$6.28 - $9.38 $737,655 - $1.1 Million	117,461 New	117,461 $1.04 Million
Q1 2022 May 13, 2022	SELL	$10.37 - $12.73 $729,736 - $895,810	-70,370 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $16,336 - $24,432	-1,600 Reduced 2.22%	70,370 $790,000
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $239,555 - $294,549	17,026 Added 30.99%	71,970 $1.05 Million
Q2 2021 Aug 13, 2021	BUY	$16.62 - $18.94 $12,581 - $14,337	757 Added 1.4%	54,944 $953,000
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $5,544 - $7,239	366 Added 0.68%	54,187 $936,000
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $13,960 - $16,286	828 Added 1.56%	53,821 $993,000
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $361,669 - $473,457	-23,485 Reduced 30.71%	52,993 $919,000
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $16,142 - $18,983	-885 Reduced 1.14%	76,478 $1.4 Million
Q1 2020 May 14, 2020	BUY	$16.28 - $25.63 $54,831 - $86,321	3,368 Added 4.55%	77,363 $1.57 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $11,742 - $14,112	600 Added 0.82%	73,995 $1.74 Million
Q3 2019 Nov 13, 2019	BUY	$19.85 - $22.76 $646,296 - $741,042	32,559 Added 79.73%	73,395 $1.49 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $11,785 - $14,137	670 Added 1.67%	40,836 $885,000
Q1 2019 May 14, 2019	BUY	$18.01 - $20.11 $20,963 - $23,408	1,164 Added 2.98%	40,166 $825,000
Q4 2018 Feb 13, 2019	SELL	$17.44 - $21.53 $17,317 - $21,379	-993 Reduced 2.48%	39,002 $706,000
Q3 2018 Nov 13, 2018	BUY	$19.97 - $21.96 $16,335 - $17,963	818 Added 2.09%	39,995 $881,000
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $460,615 - $563,888	22,848 Added 139.92%	39,177 $863,000
Q1 2018 May 11, 2018	BUY	$20.31 - $24.95 $30,688 - $37,699	1,511 Added 10.2%	16,329 $361,000
Q4 2017 Feb 14, 2018	BUY	$20.99 - $23.89 $46,639 - $53,083	2,222 Added 17.64%	14,818 $351,000
Q3 2017 Nov 13, 2017	BUY	$20.07 - $21.89 $252,801 - $275,726	12,596	12,596 $0

Others Institutions Holding GRFS

# of Institutions

176

Shares Held

153M

Call Options Held

42.9K

Put Options Held

82.4K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.34B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Grifols Sa Transaction History